On March 8, 2013 a Los Angeles jury awarded $8.3 million in compensatory damages to the Plaintiff, Loren “Bill” Kransky, in the four week jury trial against Johnson & Johnson’s DePuy subsidiary. The jury concluded that DePuy was liable for the design defects in its DePuy ASR XL product and the damages it caused to…
Read More
According to a new warning from the Food and Drug Administration (FDA), a popular antibiotic used to treat bacterial infections can cause abnormal changes in the electrical activity of the heart that may lead to a potentially fatal irregular heart rhythm. The drug, azithromycin (Zithromax or Zmax), is commonly sold in what is called a…
Read More
Last week, a South Dakota jury ordered Johnson & Johnson to pay a woman $3.35 million for failing to adequately warn her doctor of the potential dangers of a vaginal mesh implant and for misrepresenting the product in brochures. The verdict marks the first among 1,800 vaginal mesh cases currently pending in New Jersey against…
Read More
A Massachusetts family has recently been awarded $63 million against Johnson & Johnson after a young girl suffered severe side effects from taking Children’s Motrin. The family of Samantha Reckis will ultimately receive $109 million with interest as the injury occurred a decade ago. At the time of the incident in 2003, Reckis was 7…
Read More
On February 22, 2013, the U.S. Food & Drug Administration (FDA) posted that it notified healthcare professionals regarding a Class I recall of the LPS Diaphyseal Sleeve. The LPS Diaphyseal Sleeve is a component in the DePuy LPS System, an end-stage revision knee product that allows surgeons to reconstruct severe soft tissue and bony defects….
Read More
According to a recent study, hip replacements are more likely to fail in women than in men. Researchers found that although the overall risk of implants failing is low, women were 29 percent more likely than men to need a repeat hip replacement surgery within the first three years. The study, which was funded by…
Read More
On January 25, 2013, opening statements began in a trial that will likely have major implications on more than 10,000 lawsuits filed against Johnson & Johnson. The case of Kransky v. DePuy, et.al. is the first of many impending claims against Johnson & Johnson for its DePuy ASR XL product to reach trial. The DePuy…
Read More
In an article published just yesterday by The New York Times, we learned that newly disclosed court records show that Johnson & Johnson, and its subsidiary DePuy Orthopaedics, Inc., were aware of an alarmingly high failure rate in their metal on metal hip implants back in 2011. According to the article, the manufacturers conducted an…
Read More